Stocktoria
FibroBiologics, Inc. FBLG
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2024-01-31
FibroBiologics, Inc. statistics & valuation
Market cap$4.3M
P / B0.7×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Return on assets | -193.8% | -67.9% | -139.5% | -106.2% |
| Return on equity | -302.9% | -408.1% | -1315.6% | 128.2% |
| Current ratio | 3.61 | 1.12 | 1.00 | 0.37 |
Source: SEC EDGAR filings · CIK 0001958777 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.